Obesity in primary care: prevention, management and the paradox

BMC Medicine

David Haslam¹ 

[1] GP Watton at Stone, Hertfordshire, Centre for Obesity research, Luton & Dunstable Hospital, Bedfordshire, UK

关键词: Weight;    Obesity management;    Obesity paradox;    Primary care;    Obesity;   

Others  :  1121506
DOI  :  10.1186/1741-7015-12-149

 received in 2014-05-12, accepted in 2014-05-12,  发布年份 2014

【 摘 要 】

Government and societal efforts to combat obesity are aimed at prevention, although there is a generation for whom excess weight is the rule rather than the exception. Although measures to prevent a worsening of the current epidemic are important, management of obesity must also be prioritised. Obesity management is beset with problems ranging from attitudinal to clinical and pharmacological, and the individualisation of therapy.

【 授权许可】

   
2014 Haslam; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Edwards D: Healthier Choices Pilot; An independent behaviour change study to explore the potential to encourage healthier choices in a supermarket environment. 2013. http://www.healthierchoicespilot.com/pdf/health-lab-report.pdf webcite
• [2]Counterweight Project Team: Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract 2008, 58:548-554.
• [3]Nanchahal K, Power T, Holdsworth E, Elizabeth H, Michelle H, Annik S, Ulla G, Joy T, Nicki T, David H, Anthony K, Shah E, Mike K, Andrew H: A pragmatic randomised controlled trial in primary care of the Camden weight loss (CAMWEL) programme. BMJ Open 2012, 2:e000793.
• [4]Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Look AHEAD Research Group, et al.: Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013, 369:145-154.
• [5]Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
• [6]Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J, Finnish Diabetes Prevention Study Group: The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003, 26:3230-3236.
• [7]Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR, Kraemer HC, King AC: Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA 2007, 297:969-977.
• [8]Blair SN, Kohl HW III, Barlow CE, Paffenbarger RS, Gibbons LW, Macera CA: Changes in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men. JAMA 1995, 273:1093-1108.
• [9]Rossner S, Sjostrum L, Noack R, Meinders AE, Noseda G: Weight loss, weight maintenance and improved cardiac risk factors after 2 years of treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res 2000, 8:49-61.
• [10]James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL, SCOUT Investigators: Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010, 363:905-917.
• [11]Caterson D, Finer N, Coutinho W, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Legler UF, Shepherd GM, Rode RA, Perdok RJ, Renz CL, James WP, SCOUT Investigators: Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes Obes Metab 2012, 14:523-530.
• [12]Wadden TA, Hollander P, Klein S, Niswender K, Woo V, Hale PM, Aronne L, NN8022-1923 Investigators: Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. Int J Obes (Lond) 2013, 37:1443-1451.
• [13]Lavie CJ, Milani RV, Ventura HO: Body Composition and Heart Failure Prevalence and Prognosis: Getting to the Fat of the Matter in the “Obesity Paradox”. Mayo Clin Proc 2010, 85:605-608.
• [14]Katsnelson M, Rundek T: Obesity paradox and stroke, noticing the (fat) man behind the curtain. Stroke 2011, 42:3331-3332.
• [15]Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA: Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008, 156:13-22.
• [16]Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F: Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006, 368:666-678.
• [17]Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, Pepine CJ: Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007, 120:863-870.
• [18]Arena R, Lavie CJ: The obesity paradox and outcome in heart failure: is excess bodyweight truly protective? Future Cardiol 2010, 6:1-6.
• [19]Doehner W, Erdmann E, Cairns R, Clark AL, Dormandy JA, Ferrannini E, Anker SD: Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol 2012, 162:20-26.
• [20]Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF: Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006, 355:763-778.